Oncology [TOI] vs Tenet Healthcare [THC] Detailed Stock Comparison

The Oncology Institute Inc.

NASDAQ
Loading...

Tenet Healthcare Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: The Oncology Institute Inc. wins in 5 metrics, Tenet Healthcare Corporation wins in 13 metrics, with 0 ties. Tenet Healthcare Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric The Oncology Institute Inc. Tenet Healthcare Corporation Better
P/E Ratio (TTM) N/A 12.17 N/A
Price-to-Book Ratio -20.91 3.88 Tenet Healthcare Corporation
Debt-to-Equity Ratio -6.60 160.79 Tenet Healthcare Corporation
PEG Ratio -21.50 10.76 Tenet Healthcare Corporation
EV/EBITDA -14.08 7.05 Tenet Healthcare Corporation
Profit Margin (TTM) -12.06% 6.60% Tenet Healthcare Corporation
Operating Margin (TTM) -4.87% 17.46% Tenet Healthcare Corporation
EBITDA Margin (TTM) N/A 17.46% N/A
Return on Equity 320.01% 27.02% The Oncology Institute Inc.
Return on Assets (TTM) -13.37% 8.04% Tenet Healthcare Corporation
Free Cash Flow (TTM) $-27.79M $2.53B Tenet Healthcare Corporation
1-Year Return 114.98% 6.26% The Oncology Institute Inc.
Price-to-Sales Ratio (TTM) 0.68 0.77 The Oncology Institute Inc.
Enterprise Value $410.19M $32.68B Tenet Healthcare Corporation
EV/Revenue Ratio 0.82 1.53 The Oncology Institute Inc.
Gross Profit Margin (TTM) 16.04% 81.73% Tenet Healthcare Corporation
Revenue per Share (TTM) $5 $236 Tenet Healthcare Corporation
Earnings per Share (Diluted) $-0.54 $15.48 Tenet Healthcare Corporation
Beta (Stock Volatility) 0.20 1.50 The Oncology Institute Inc.
Short % of Float 10.12% 3.55% Tenet Healthcare Corporation

The Oncology Institute Inc. vs Tenet Healthcare Corporation Stock Performance Analysis

Loading Price Chart...

TOI
THC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
The Oncology Institute Inc.-2.45%2.17%30.15%51.91%37.40%41.14%
Tenet Healthcare Corporation2.55%9.88%-8.92%-18.33%-9.23%-10.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
The Oncology Institute Inc.114.98%756.45%-47.43%-46.04%-46.04%-46.04%
Tenet Healthcare Corporation6.26%122.70%164.92%543.08%581.20%489.27%

Performance & Financial Health Analysis: The Oncology Institute Inc. vs Tenet Healthcare Corporation

MetricTOITHC
Market Information
Market Cap i$323.20M$16.50B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,461,7311,231,387
90 Day Avg. Volume i2,155,5471,117,252
Last Close$5.18$179.11
52 Week Range$2.02 - $5.57$146.60 - $247.21
% from 52W High-7.09%-27.55%
All-Time High$12.66 (Dec 27, 2021)$247.21 (Mar 05, 2026)
% from All-Time High-59.08%-27.55%
Growth Metrics
Quarterly Revenue Growth0.42%0.09%
Quarterly Earnings Growth0.42%0.17%
Financial Health
Profit Margin (TTM) i-0.12%0.07%
Operating Margin (TTM) i-0.05%0.17%
Return on Equity (TTM) i3.20%0.27%
Debt to Equity (MRQ) i-6.60160.79
Cash & Liquidity
Book Value per Share (MRQ)$-0.16$48.53
Cash per Share (MRQ)$0.34$33.15
Operating Cash Flow (TTM) i$-24,587,000$3.54B
Levered Free Cash Flow (TTM) i$-11,004,375$1.68B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: The Oncology Institute Inc. vs Tenet Healthcare Corporation

MetricTOI (Apr 24, 2026)THC (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A12.17
Forward P/E i-21.5010.76
PEG Ratio i-21.5010.76
Price to Sales (TTM) i0.680.77
Price to Book (MRQ) i-20.913.88
Market Capitalization
Market Capitalization i$323.20M$16.50B
Enterprise Value i$410.19M$32.68B
Enterprise Value Metrics
Enterprise to Revenue i0.821.53
Enterprise to EBITDA i-14.087.05
Risk & Other Metrics
Beta i0.201.50
Book Value per Share (MRQ) i$-0.16$48.53

Financial Statements Comparison: The Oncology Institute Inc. vs Tenet Healthcare Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTOI (2025)THC (2025)
Revenue/Sales i502.73M21.31B
Cost of Goods Sold i426.29M3.78B
COGS % of Revenue i84.8%17.7%
Gross Profit i76.44M17.53B
Gross Margin i15.2%82.3%
Research & Development iN/AN/A
Operating Income (EBIT) i-36.08M3.44B
Operating Margin i-7.2%16.1%
EBITDA i-30.06M4.68B
EBITDA Margin i-6.0%22.0%
Pre-Tax Income i-60.74M2.80B
Pre-Tax Income % of Revenue i-12.1%13.1%
Income Tax i-131,000433.00M
Income Tax % of Revenue i0.0%2.0%
Net Income (Profit) i-60.61M1.41B
Profit Margin i-12.1%6.6%

Balance Sheet & Liquidity Metrics

MetricTOI (2025)THC (2025)
Cash & Equivalents i33.57M2.88B
Total Current Assets i112.75M7.85B
Total Current Assets % of Revenue i22.4%36.8%
Total Current Liabilities i70.96M4.46B
Total Current Liabilities % of Revenue i14.1%20.9%
Long-Term Debt i96.53M13.09B
Long-Term Debt % of Revenue i19.2%61.4%
Total Shareholders Equity i-15.72M8.97B
Retained Earnings i-271.42M4.42B
Retained Earnings % of Revenue i-54.0%20.7%
Property, Plant & Equipment i24.08M6.71B

Cash Flow Statement Comparison

MetricTOI (2025)THC (2025)
Operating Cash Flow i-41.02M3.51B
Operating Cash Flow % of Revenue i-8.2%16.5%
Capital Expenditures i-3.20M-972.00M
Free Cash Flow i-27.79M2.53B
FCF Margin i-5.5%11.9%
Debt Repayment i-20.04M-2.37B
Common Stock Repurchase iN/A-1.39B

Short Interest & Institutional Ownership Analysis

MetricTOITHC
Shares Short i8.30M2.28M
Short Ratio i3.362.20
Short % of Float i10.12%3.55%
Shares Outstanding i98.86M86.95M
Float Shares i64.83M85.97M
% Held by Insiders i20.14%1.08%
% Held by Institutions i45.02%98.33%
% Held by Public i34.84%0.59%

Dividend Analysis & Yield Comparison: The Oncology Institute Inc. vs Tenet Healthcare Corporation

MetricTOITHC
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A